CBT at a glance
CABOT CORP (CBT, SEC CIK 16040) filed its latest 10-K annual report on November 20, 2026, a 10-Q quarterly report on August 4, 2026, an 8-K current report on November 2, 2026 and Form 4 insider filings as recently as November 20, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.
- For the fiscal year ended September 30, 2026 (FY2026), CABOT CORP (CBT) reported revenue of $3.7 billion (up 0.8% from FY2025) and net income of $213.0 million. Diluted EPS was $4.02.
- As of September 30, 2026, 30 institutional investment managers tracked by SignalX reported holding CABOT CORP (CBT) shares worth $1.9 billion in 13F-HR filings.
- In the last 90 days, CBT insiders reported 0 open-market purchases ($0) and 2 open-market sales ($11.7M) on Form 4, a net sale of $11.7M.
Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).
- Revenue · FY2026
- $3.7B
- +0.8% vs prior year
- Insiders · 90 days
- 0 buys · 2 sells
- Net −$11.7M
- 13F holders
- 30 funds
- $1.9B · −3 vs prior quarter
- Latest 8-K
- Nov 2, 2026
- Item 2.02
AI 10-K Annual Report Analysis
Latest 10-K, fiscal year ended Sep 30, 2026
Business Overview
- Core model: Global specialty chemicals and performance materials, organized into Reinforcement Materials and Performance Chemicals
- Battery materials emphasis: Conductive additives, carbon nanotubes and nano structures for electric vehicles and energy storage systems
- Portfolio reshaping: Campana, Argentina carbon black operations ceased in May 2026, with multiple Botlek, Netherlands units planned for closure in fiscal 2027
- Geographic exposure: China represented approximately 27% of fiscal 2026 revenues and 21% of property, plant and equipment
- Fiscal 2026 investment: Approximately $54 million in technology development, focused partly on battery additives and lower-emissions processes
Risk Factors
- EU ETS and tightening NOx, SO₂ and particulate limits: higher compliance costs and threatened carbon black asset viability
- China exposure: 27% of fiscal 2026 revenue and 21% of property, plant and equipment, with unpredictable government production curtailments
- Dow shutdown at Barry, Wales: lost chlorosilane feedstock forced cessation of hydrophilic fumed silica production
- Chinese battery manufacturers: local western battery production challenges threatening Cabot’s battery materials growth investments
- Reinforcement Materials concentration: one-year customer contracts represent approximately half of reinforcing carbons volumes
Management Discussion & Analysis
- Revenue $3.744B, up $31M YoY, driven by higher volumes and foreign currency translation
- Net income $213M vs $331M; Reinforcement Materials EBIT down $129M, Performance Chemicals EBIT up $41M
- Reinforcement Materials worst segment: sales $2.297B vs $2.341B; Performance Chemicals best: sales $1.319B vs $1.250B
- Operating cash flow $421M vs $665M; capex $207M; buybacks $146M; common dividends $97M
- Fiscal 2027 outlook: operating tax rate 28%-30%, capex $200M-$230M, risks from volatile energy costs and competitive pressures
AI summary of the CBT 10-K filed . Generated from the filing text; verify against the original.View on SEC EDGARHow to read a 10-K
AI 10-Q Quarterly Report Analysis
Latest 10-Q, quarter ended Jun 30, 2026
Management Discussion & Analysis
- Q3 revenue $982M, up $59M YoY from $923M
- Gross profit $184M vs $244M YoY; gross margin 18.7% vs 26.4%
- Performance Chemicals best segment: sales $351M, EBIT $68M vs $57M YoY
- Reinforcement Materials weakest segment: EBIT $97M vs $128M YoY
- Cash $250M; operating cash flow $278M vs $446M YoY, with $152M capital expenditures
- Q4 outlook: EBIT declines expected in both segments from lower volumes and normalized gross profit per ton
AI summary of the CBT 10-Q filed . Generated from the filing text; verify against the original.View on SEC EDGAR10-K vs 10-Q vs 8-K
AI 8-K Current Report Analysis
The most recent material events, by 8-K item
Item 2.02: Results of Operations and Financial Condition
- Fiscal quarter ended September 30, 2026 results announced
- Press release provides Cabot’s operating results and financial details in Exhibit 99.1
Item EX-99.1: Item EX-99.1
- FY2026 revenue $3.744B, while GAAP EPS fell to $4.02 from $6.02 and Adjusted EPS to $6.42 from $7.25
- Fourth-quarter Adjusted EPS $1.61, supported by Performance Chemicals EBIT $60M, up $18M year over year
Item 5.02: Departure/Appointment of Directors or Principal Officers
- Steven J. Delahunt becomes interim CFO effective October 1, 2026, replacing Erica McLaughlin
- McLaughlin’s transition to President and CEO creates a concurrent CFO succession need
Item EX-99.1: Item EX-99.1
- Steve Delahunt becomes interim CFO October 1, 2026, while Cabot searches for a permanent finance chief
- Erica McLaughlin transitions from CFO to CEO October 1, 2026, succeeding Sean Keohane
Item 7.01: Regulation FD Disclosure
- Press release announces Cabot management transition, a potentially material leadership and execution development
- Investors should review Exhibit 99.1 for incoming and departing executives, timing, and succession implications
Item 8.01: Other Events
- $350 million senior notes issued August 21, 2026, carrying 4.950% interest and maturing in 2029
- Proceeds earmarked to redeem $250 million of 3.40% notes due September 2026
AI summaries of CBT 8-K current reports filed with the SEC. What 8-K item codes mean
SignalX for CBT
Don't miss the next CBT filing
- Alerts as it files. A push when CBT files an 8-K or an insider trades.
- Fund moves. Which tracked funds opened, added or cut CBT, by share count.
- Ask anything. An AI agent that reads every CBT filing and answers with sources.
Recent Insider Transactions (Form 4)
Latest reported trades by officers, directors and 10% owners
| Insider | Type | Date | Shares | Price |
|---|---|---|---|---|
| McLaughlin Erica | A | Nov 18, 2026 | 5,054 | - |
| Delahunt Steven J | F | Nov 18, 2026 | 324 | $74.03 |
| Dumont Lisa M | A | Nov 18, 2026 | 592 | - |
| Zhu Jeff Ji | F | Nov 18, 2026 | 1,623 | $74.03 |
| McLaughlin Erica | F | Nov 18, 2026 | 3,961 | $74.03 |
| Delahunt Steven J | A | Nov 18, 2026 | 562 | - |
| Masterson William F III | A | Nov 18, 2026 | 1,549 | - |
| Masterson William F III | F | Nov 18, 2026 | 260 | $74.03 |
Financial SummaryXBRL
| Metric | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
| Profitability | |||
| Revenue | - | $3.7B | $3.7B |
| Gross Profit | - | $940.0M | $809.0M |
| Operating Income | - | $621.0M | $477.0M |
| Net Income | - | $331.0M | $213.0M |
| Gross Margin | - | 25.3% | 21.6% |
| Op. Margin | - | 16.7% | 12.7% |
| Net Margin | - | 8.9% | 5.7% |
| Balance Sheet | |||
| Total Assets | $3.7B | $3.8B | $4.0B |
| Equity | - | $1.6B | $1.6B |
| ROE | - | 21.4% | 13.0% |
| Per Share | |||
| EPS | - | $6.02 | $4.02 |
| Cash Flow | |||
| Operating CF | - | $665.0M | $421.0M |
| CapEx | $241.0M | $274.0M | $207.0M |
Source: XBRL data in CABOT CORP (CBT)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →
13F Fund Holdings: Quarterly Trend
Latest: Q3 2026Aggregate CBT share value held by 13F filers tracked by SignalX, by quarter.
Quarterly totals table
| Quarter | Funds | Total value |
|---|---|---|
| Q3 2026 | 30 | $1.88B |
| Q2 2026 | 33 | $2.37B |
| Q1 2026 | 33 | $1.86B |
| Q4 2025 | 32 | $1.64B |
| Q3 2025 | 31 | $1.85B |
| Q2 2025 | 30 | $1.80B |
| Q1 2025 | 30 | $1.48B |
| Q4 2024 | 26 | $1.47B |
- Dimensional Fund Advisors+195.3K (+10%)
- Goldman Sachs Group+117.0K (+23%)
- Morgan Stanley+85.6K (+10%)
- BlackRock+80.8K (+1%)
- AQR Capital Management+51.8K (+6%)
- Millennium Management−417.2K (-85%)
- Invesco Ltd−161.3K (-54%)
- Franklin Resources−124.1K (-86%)
- Bridgewater Associates LP−44.2K (-93%)
- Citigroup−29.8K (-33%)
- FMR LLC (Fidelity)−1.56M
- Equitable Holdings Inc−5.5K
- Mangrove Partners−2.4K
Source: 13F-HR filings on SEC EDGAR (aggregated from 245 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work
CBT filing archive
AI analysis pages for each 10-K, 10-Q and 8-K
10-K annual reports
10-Q quarterly reports
Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4
| Form | Filing date | Period | Analysis | SEC |
|---|---|---|---|---|
| 4 | Nov 20, 2026 | - | - | - |
| 10-K | Nov 20, 2026 | Sep 30, 2026 | Analysis | |
| 4 | Nov 20, 2026 | - | - | - |
| 4 | Nov 20, 2026 | - | - | - |
| 4 | Nov 20, 2026 | - | - | - |
| 4 | Nov 20, 2026 | - | - | - |
| 4 | Nov 20, 2026 | - | - | - |
| 4 | Nov 17, 2026 | - | - | - |
| 4 | Nov 17, 2026 | - | - | - |
| 4 | Nov 17, 2026 | - | - | - |
| 4 | Nov 17, 2026 | - | - | - |
| 4 | Nov 17, 2026 | - | - | - |
| 4 | Nov 17, 2026 | - | - | - |
| 4 | Nov 12, 2026 | - | - | - |
| 4 | Nov 12, 2026 | - | - | - |
| 4 | Nov 12, 2026 | - | - | - |
| 4 | Nov 12, 2026 | - | - | - |
| 4 | Nov 12, 2026 | - | - | - |
| 4 | Nov 12, 2026 | - | - | - |
| 8-K | Nov 2, 2026 | - | Analysis | - |
| 4 | Oct 1, 2026 | - | - | - |
| 4 | Oct 1, 2026 | - | - | - |
| 4 | Oct 1, 2026 | - | - | - |
| 4 | Oct 1, 2026 | - | - | - |
| 4 | Oct 1, 2026 | - | - | - |
Related Materials companies
- ARQ · Arq, Inc.Miscellaneous Chemical Products
- AEM · Agnico Eagle Mines LtdGold and Silver Ores
- APD · Air ProductsIndustrial Inorganic Chemicals
- ALB · Albemarle CorporationPlastic Materials, Synth Resins & Nonvulcan Elastomers
- AA · Alcoa CorpPrimary Production of Aluminum
- AMCR · AmcorMiscellaneous Manufacturing Industries
- ABAT · AMERICAN BATTERY TECHNOLOGY CoMining & Quarrying of Nonmetallic Minerals (No Fuels)
- AMWD · AMERICAN WOODMARK CORPMillwood, Veneer, Plywood, & Structural Wood Members
CBT SEC filings: frequently asked questions
Are CBT insiders buying or selling?
In the last 90 days, CABOT CORP (CBT) officers, directors and 10% owners reported no open-market purchases and 2 open-market sales worth $11.7 million by 1 insider on Form 4. Many insider sales are pre-planned or for taxes, so purchases usually carry more information.
Which institutions hold CBT stock?
As of September 30, 2026, the largest CABOT CORP (CBT) holders among the 13F filers tracked by SignalX were BlackRock ($542.5 million), Vanguard Portfolio Management LLC ($236.7 million), Vanguard Capital Management LLC ($178.4 million), State Street Corp ($167.4 million), Dimensional Fund Advisors ($163.2 million). 13F-HR reports are filed up to 45 days after each quarter ends.
What was CBT's revenue in fiscal year 2026?
For the fiscal year ended September 30, 2026 (FY2026), CABOT CORP (CBT) reported revenue of $3.7 billion (up 0.8% from FY2025) and net income of $213.0 million. Diluted EPS was $4.02. The figures come from the XBRL data in the 10-K.
What are the main risks in CBT's latest 10-K?
In the 10-K filed November 20, 2026, CABOT CORP (CBT) flagged: EU ETS and tightening NOx, SO₂ and particulate limits: higher compliance costs and threatened carbon black asset viability. China exposure: 27% of fiscal 2026 revenue and 21% of property, plant and equipment, with unpredictable government production curtailments. (AI summary of the Risk Factors section.)
What did CBT report in its latest 8-K?
CABOT CORP (CBT) filed an 8-K on November 2, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Fiscal quarter ended September 30, 2026 results announced.
What are the latest CBT SEC filings?
CABOT CORP (CBT) filed its latest 10-K annual report on November 20, 2026, a 10-Q quarterly report on August 4, 2026, an 8-K current report on November 2, 2026 and a Form 4 insider filing on November 20, 2026.
What is CBT's SEC CIK number?
CABOT CORP (CBT)'s SEC Central Index Key (CIK) is 16040. EDGAR lists every CBT filing under that number.
Ask anything about CBT
The research agent reads CBT's filings, financials, insider trades and 13F holders, then answers with sources.